OnLume Surgical announced recently that it has closed a $7 million Series A financing round.

“The completion of the Series A financing, plus the Phase II grant from NCI, provides the resources for important milestones ahead during the next 24 months,” OnLume CEO James Bowman said in a statement. “These activities include commercial launch into our first market vertical and progress on other market opportunities.”

According to a release, the funds will be used to assist OnLume’s plans for commercial launch.

Cambridge Investment Group led the round, with participation from Wisconsin Alumni Research Foundation and Wisconsin Investment Partners.